Targeting cancer stem cells with ribosome-inactivating proteins: from molecular mechanisms to clinical translation.
- DOI
- 10.1080/14737140.2026.2738622
- Published
- 2026 Sep 23
- Container
- Expert review of anticancer therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14737140.2026.2738622,
title = {Targeting cancer stem cells with ribosome-inactivating proteins: from molecular mechanisms to clinical translation.},
author = {Rai A and Vikram A and Singh TP and Sharma P and Sharma S},
year = {2026},
journal = {Expert review of anticancer therapy},
doi = {10.1080/14737140.2026.2738622},
url = {https://doi.org/10.1080/14737140.2026.2738622}
}RIS
TY - JOUR TI - Targeting cancer stem cells with ribosome-inactivating proteins: from molecular mechanisms to clinical translation. AU - Rai A AU - Vikram A AU - Singh TP AU - Sharma P AU - Sharma S PY - 2026 JO - Expert review of anticancer therapy DO - 10.1080/14737140.2026.2738622 UR - https://doi.org/10.1080/14737140.2026.2738622 ER -
APA
A, R., A, V., TP, S., P, S., & S, S. (2026). Targeting cancer stem cells with ribosome-inactivating proteins: from molecular mechanisms to clinical translation.. Expert review of anticancer therapy. https://doi.org/10.1080/14737140.2026.2738622
Source records
- pubmed · retrieved 2026-09-26T03:06:15.026Z